Sideroblastic anemia

Last updated: September 12, 2024

Sideroblastic anemia

Block 3 CVH

Block 3 CVH

Angina pectoris
Stable angina
Ludwig angina
Unstable angina
Prinzmetal angina
Heart failure
Heart failure: Pathology review
Stroke volume, ejection fraction, and cardiac output
Congestive heart failure: Clinical sciences
Dilated cardiomyopathy
Restrictive cardiomyopathy
Frank-Starling relationship
Myocardial infarction
Acute coronary syndrome: Clinical sciences
ECG cardiac infarction and ischemia
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
cGMP mediated smooth muscle vasodilators
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Coronary artery disease: Clinical sciences
Adrenergic antagonists: Beta blockers
Calcium channel blockers
Coronary artery disease: Pathology review
Hereditary spherocytosis
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Approach to anemia (destruction and sequestration): Clinical sciences
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Lead poisoning
Oxygen-hemoglobin dissociation curve
Sickle cell disease (NORD)
Sickle cell disease: Clinical sciences
Beta-thalassemia
Beta-thalassemia: Year of the Zebra
Alpha-thalassemia
Mitral valve disease
Valvular heart disease: Pathology review
Valvular insufficiency (regurgitation): Clinical sciences
Abnormal heart sounds
Aortic stenosis: Clinical sciences
Aortic valve disease
Infectious endocarditis: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Persistent truncus arteriosus
Transposition of the great vessels
Approach to congenital heart diseases (cyanotic): Clinical sciences
Tetralogy of Fallot
Tetralogy of Fallot: Year of the Zebra
Total anomalous pulmonary venous return
Ventricular septal defect
Approach to congenital heart diseases (acyanotic): Clinical sciences
Atrial septal defect
Patent ductus arteriosus
Acyanotic congenital heart defects: Pathology review
Coarctation of the aorta
Cardiac tumors
Cardiac and vascular tumors: Pathology review
Carcinoid syndrome
Hypertension: Pathology review
Hypertension
Hypertensive emergency
Pulmonary hypertension
Essential hypertension: Clinical sciences
Pulmonary hypertension: Clinical sciences
Approach to hypertension: Clinical sciences
Cor pulmonale
Pulmonary arterial hypertension (NORD)
Cardiomyopathies: Pathology review
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy: Clinical sciences
Cardiac conduction velocity
Cardiac conduction system
ECG cardiac hypertrophy and enlargement
ECG axis
ECG intervals
ECG basics
ECG QRS transition
ECG rate and rhythm
ECG normal sinus rhythm
Atrial fibrillation
Supraventricular arrhythmias: Pathology review
Atrial flutter
Ventricular fibrillation
Ventricular arrhythmias: Pathology review
Atrioventricular block: Clinical sciences
Atrioventricular block
Heart blocks: Pathology review
Long QT syndrome and Torsade de pointes
Brugada syndrome
Pericarditis and pericardial effusion
Pericarditis: Clinical sciences
Recurrent pericarditis (NORD)
Pericardial disease: Pathology review
Cardiac tamponade: Clinical sciences
Myocarditis
Shock
Approach to shock: Clinical sciences
Shock: Pathology review
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Iron deficiency anemia
Iron deficiency anemia: Clinical sciences
Anemia of chronic disease: Year of the Zebra
Anemia of chronic disease
Folate (Vitamin B9) deficiency
Anemia in pregnancy: Clinical sciences
Vitamin B12 deficiency
Vitamin B12 deficiency: Clinical sciences
Orotic aciduria
Diamond-Blackfan anemia
Sideroblastic anemia
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Acute intermittent porphyria
Porphyria cutanea tarda
Aplastic anemia
Non-hemolytic normocytic anemia: Pathology review
Fanconi anemia
Megaloblastic anemia
Macrocytic anemia: Pathology review
Autoimmune hemolytic anemia
Microcytic anemia: Pathology review
Pernicious anemia: Year of the Zebra
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Acute leukemia
Approach to leukemia: Clinical sciences
Leukemias: Pathology review
Approach to myeloproliferative neoplasms: Clinical sciences
Chronic leukemia
Myeloproliferative disorders: Pathology review
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Approach to lymphoma: Clinical sciences
Hodgkin lymphoma
Multiple myeloma: Clinical sciences
Multiple myeloma
Waldenstrom macroglobulinemia
Plasma cell disorders: Pathology review
Amyloidosis
Monoclonal gammopathy of undetermined significance
Myelodysplastic syndromes
Approach to myelodysplastic syndromes: Clinical sciences
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Mastocytosis (NORD)
Langerhans cell histiocytosis
Langerhans cell histiocytosis: Year of the Zebra
Non-steroidal anti-inflammatory drugs
Antiplatelet medications
Anticoagulants: Direct factor inhibitors
Thrombolytics
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Anticoagulants: Warfarin
Osmotic diuretics
Sympatholytics: Alpha-2 agonists
Sympathomimetics: Direct agonists
Wiskott-Aldrich syndrome
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Premature ventricular contraction
Supraventricular tachycardia: Clinical sciences
Wolff-Parkinson-White syndrome
Anatomy clinical correlates: Heart
Approach to bradycardia: Clinical sciences
Premature atrial contraction
Bundle branch block
Approach to a murmur (pediatrics): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Cyanotic congenital heart defects: Pathology review
Williams syndrome
Hypoplastic left heart syndrome
Hypoplastic left heart syndrome: Year of the Zebra 2024
Kawasaki disease
Kawasaki disease: Clinical sciences
Approach to chest pain: Clinical sciences
Ventricular tachycardia: Clinical sciences
Approach to syncope: Clinical sciences
Approach to tachycardia: Clinical sciences
Atrioventricular nodal reentrant tachycardia (AVNRT)
Approach to acid-base disorders: Clinical sciences
Acid-base map and compensatory mechanisms
The role of the kidney in acid-base balance
Acid-base disturbances: Pathology review
Plasma anion gap
Approach to metabolic acidosis: Clinical sciences
Metabolic acidosis
Metabolic alkalosis
Respiratory alkalosis
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Renal tubular acidosis
Respiratory acidosis
Approach to respiratory acidosis: Clinical sciences
Neuroblastoma
Neuroblastoma: Year of the Zebra 2024
Nephroblastoma (Wilms tumor)

Transcript

Watch video only

With sideroblastic anemia, sidero- means iron and -blastic meaning immature and anemia refers to a condition where there’s a decrease in the number of healthy red blood cells, or RBCs in the body.

So sideroblastic anemia is a type of blood disorder where there’s a buildup of iron in the RBC’s in the body causing them to be immature and dysfunctional.

This buildup occurs because these RBC’s are unable to incorporate iron into hemoglobin which is necessary for RBC’s to transport oxygen.

In order to better understand sideroblastic anemia, we need to first take a look at hemoglobin, the main protein within RBC’s that’s responsible for carrying oxygen.

Now hemoglobin is made up of hemes and globins.

There are 4 globin subunits, typically two alpha and two beta, and each one has its own heme group.

This heme is a large molecule that’s made up of four pyrrole subunits that forms a ring, and this structure is called a porphyrin.

In the middle, there is an ionically bond iron 2+ and the iron is what binds to and carries the oxygen molecule.

So each hemoglobin can carry four oxygen molecules when it’s fully saturated.

The process of heme synthesis occurs both within the mitochondria and the cytosol of a cell and requires multiple enzymes to catalyze the numerous steps.

It begins in the mitochondria where succinyl CoA binds to glycine via delta-ALA synthase which uses vitamin B6 as a cofactor to produce delta-aminolevulinic acid, or ALA.

Then, in the cytosol, delta-aminolevulinic acid is converted to porphobilinogen, or PBG, via delta-ALA dehydratase.

From there, four molecules of porphobilinogen condense together to form hydroxymethylbilane with the help of porphobilinogen deaminase.

Note that porphobilinogen deaminase is sometimes called uroporphyrinogen I synthase or hydroxymethylbilane synthase, or HMBS for short.

Afterwards, hydroxymethylbilane is converted to uroporphyrinogen III and catalyzed to coproporphyrinogen III via uroporphyrinogen III cosynthase and uroporphyrinogen decarboxylase, respectively.

Next, coproporphyrinogen III is brought back into the mitochondria and converted into protoporphyrinogen IX by coproporphyrinogen oxidase.

Protoporphyrinogen IX is converted to protoporphyrin IX by protoporphyrinogen oxidase.

Lastly, an iron molecule is added to protoporphyrin IX via the enzyme ferrochelatase, and 10 tongue twisters later, voila! We got ourselves a completed heme!

Now, with sideroblastic anemia, there is defective protoporphyrin synthesis which results in impaired incorporation of iron to form heme.

Sideroblastic anemia can be congenital or acquired.

The most common congenital cause is an X-linked form which means it occurs on the X chromosome and affects mainly boys since boys only have one copy of the X chromosome.

This X-link form is caused by mutations in the ALAS2 gene. The ALAS2 gene is involved in coding for delta-ALA synthase.

Without delta-ala-synthase, there is a buildup of iron and not enough normal heme production.

The acquired causes of sideroblastic anemia include excessive alcohol use, pyridoxine or vitamin B6 deficiency and lead poisoning.

Excessive alcohol consumption can lead to mitochondrial damage and nutritional deficiencies like vitamin B6, iron and folate which affects the mitochondria’s ability to form heme.

Key Takeaways

Sideroblastic anemia occurs when the bone marrow produces ringed sideroblasts rather than healthy red blood cells (erythrocytes). It is due to either a congenital abnormality or an acquired cause such as vitamin B6 deficiency, excessive alcohol use, or lead poisoning which leads to an inability to incorporate iron to form heme.

The lack of functional heme results in anemia and fatigue. Also, the overload of iron that is unable to be incorporated into RBCs can damage other organs. Diagnosis of sideroblastic anemia involves a medical history and physical examination, along with tests like full blood count and peripheral blood smear. Treatment involves the removal of toxins and the administration of vitamin B6, thiamine, and folic acid.

Sources

  1. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  2. "X-Linked, Pyridoxine-Responsive Sideroblastic Anemia" New England Journal of Medicine (1994)
  3. "Robbins Basic Pathology" Elsevier (2017)
  4. "Sideroblastic anemias." Wintrobe's Clinical Hematology. 10th ed. (1999)
  5. "Sideroblastic Anemias" Merck Manual Professional Version (2020)